BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3083202)

  • 1. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK; Ansari NH; Hair GA; Awasthi S; Das B
    Metabolism; 1986 Apr; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK; Hair GA; Das B
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7222-6. PubMed ID: 3933003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of aldose reductase from human tissues.
    Das B; Srivastava SK
    Diabetes; 1985 Nov; 34(11):1145-51. PubMed ID: 3930326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
    Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A; Liu SQ; Das B; Ansari NH; Srivastava SK
    Biochem Pharmacol; 1990 Mar; 39(6):1115-24. PubMed ID: 2157439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of aldose reductase by nonenzymatic glycosylation.
    Srivastava SK; Ansari NH; Bhatnagar A; Hair G; Liu S; Das B
    Prog Clin Biol Res; 1989; 304():171-84. PubMed ID: 2506561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM; Schofield PJ; Edwards MR
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldehyde and aldose reductases from human placenta. Heterogeneous expression of multiple enzyme forms.
    Vander Jagt DL; Hunsaker LA; Robinson B; Stangebye LA; Deck LM
    J Biol Chem; 1990 Jul; 265(19):10912-8. PubMed ID: 2113526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.
    Das B; Srivastava SK
    Arch Biochem Biophys; 1985 May; 238(2):670-9. PubMed ID: 3922304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldose and aldehyde reductase in animal tissues.
    Flynn TG
    Metabolism; 1986 Apr; 35(4 Suppl 1):105-8. PubMed ID: 3083200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE; Lai CJ
    Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdetermination of aldose and aldehyde reductases from human tissues.
    Song HP; Das B; Srivastava SK
    Curr Eye Res; 1987 Aug; 6(8):1001-6. PubMed ID: 3117493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties.
    Srivastava SK; Das B; Hair GA; Gracy RW; Awasthi S; Ansari NH; Petrash JM
    Biochim Biophys Acta; 1985 Jul; 840(3):334-43. PubMed ID: 3924115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase in diabetic cataracts.
    Kinoshita JH; Kador P; Catiles M
    JAMA; 1981 Jul; 246(3):257-61. PubMed ID: 6787220
    [No Abstract]   [Full Text] [Related]  

  • 17. Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.
    Chandra D; Jackson EB; Ramana KV; Kelley R; Srivastava SK; Bhatnagar A
    Diabetes; 2002 Oct; 51(10):3095-101. PubMed ID: 12351453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of novel aldose reductase inhibitors, M16209 and M16287, in comparison with known inhibitors, ONO-2235 and sorbinil.
    Kato K; Nakayama K; Mizota M; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1540-5. PubMed ID: 1934175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldose reductase in diabetic complications of the eye.
    Kinoshita JH; Fukushi S; Kador P; Merola LO
    Metabolism; 1979 Apr; 28(4 Suppl 1):462-9. PubMed ID: 45423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.